Archive for Publications

Navigation Challenges to Participation in Phase I Clinical Trials. Cancer and Clinical Oncology 2012 Nov; 1(2):86-90.

Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG™) in Advanced Cancer.

EUS or Percutaneously Guided Intratumoral TNFerade Biologic with 5-Fluorouracil and Radiotherapy for First-Line Treatment of Locally Advanced Pancreatic Cancer…

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer.

“The clinical data generated in the report By Lu et al. involving 31 advanced lungs…” of: [Lu C et al. Phase I clinical trial of systemically administered TUSC2 (FUS1)-nanoparticles mediating functional gene transfer in humans.

PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform. PLoS ONE 2012; 7(8):e40452.

“Hanna et al. Describe a novel DNA plasmid (called BC-819) that enables expression…”

A Live-attenuated Listeria Vaccine (ANZ-100) and a Live-attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers:

Oncolytic Viruses for Induction of Anti-Tumor Immunity.

RNA Interference and Cancer Therapy.